Promacta | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Promacta
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Granules Eltrombopag

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Promacta

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

56 API Suppliers, 22 USDMF, 3 JDMF, 7 EU WC, 4 KDMF, 15 NDC API, 34 Listed Suppliers, $ API Reference Price

56 API Suppliers
22 USDMF
3 JDMF
7 EU WC
4 KDMF
15 NDC API
34 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

62 Drugs in Development

62 Drugs in Development

INTERMEDIATES

21 Intermediate Suppliers

21 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

91 FDF Dossiers, 33 FDA Orange Book, 10 Europe, 4 Canada, 16 Australia, 2 South Africa, 26 Listed Dossiers

91 FDF Dossiers
33 FDA Orange Book
10 Europe
4 Canada
16 Australia
2 South Africa
26 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 12.5MG ACID, TABLET;ORAL - EQ 25MG ACID, TABLET;ORAL - EQ 50MG ACID, TABLET;ORAL - EQ 75MG ACID

TABLET;ORAL - EQ 100MG ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 12.5MG ACID
TABLET;ORAL - EQ 25MG ACID
TABLET;ORAL - EQ 50MG ACID
TABLET;ORAL - EQ 75MG ACID

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 14 SPI Pharma, 7 DKSH, 2 Pharm-RX Chemical, 1 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Kirsch Pharma, 1 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 12 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 1 Clariant, 10 Corel Pharma Chem, 3 DFE Pharma, 10 Gangwal Chemicals, 5 Ideal Cures, 2 Ingredion Pharma Solutions, 13 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 14 Roquette, 12 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 22 Controlled & Modified Release, 22 Direct Compression, 20 Thickeners and Stabilizers, 20 Disintegrants & Superdisintegrants, 18 Solubilizers, 16 Granulation, 15 Chewable & Orodispersible Aids, 15 Taste Masking, 14 Parenteral, 12 Lubricants & Glidants, 10 Film Formers & Plasticizers, 10 Co-Processed Excipients, 9 Rheology Modifiers, 8 Topical, 6 API Stability Enhancers, 5 Empty Capsules, 5 Coloring Agents, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

47 Fillers, Diluents & Binders
46 Coating Systems & Additives
22 Controlled & Modified Release
22 Direct Compression
20 Thickeners and Stabilizers
20 Disintegrants & Superdisintegrants
18 Solubilizers
16 Granulation
15 Chewable & Orodispersible Aids
15 Taste Masking
14 Parenteral
12 Lubricants & Glidants
10 Film Formers & Plasticizers
10 Co-Processed Excipients
9 Rheology Modifiers
8 Topical
6 API Stability Enhancers
5 Empty Capsules
5 Coloring Agents
5 Emulsifying Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 27 News #PharmaBuzz

3 Data Compilation #PharmaFlow
27 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 6 Regulatory FDF Prices, 11 Annual Reports

1 US Medicaid Prescriptions
6 Regulatory FDF Prices
11 Annual Reports

MARKET PLACE

13 APIs, 7 FDF Dossiers

13 APIs
7 FDF Dossiers

PATENTS & EXCLUSIVITIES

101 US Patents, 13 US Exclusivities, 12 Health Canada Patents

101 US Patents
13 US Exclusivities
12 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP

2 USP

$ API Ref.Price (USD/KG) : 7,099 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

12 All

01 12Gowling WLG (Canada) LLP

filter Patent Reset all filters

12 All

01 42411468

02 42486697

03 42685831

filter Product Reset all filters

12 All

01 6ELTROMBOPAG OLAMINE

02 6Eltrombopag Olamine

filter Dosage Reset all filters

12 All

01 6TABLET

02 6Tablet

filter Exp Date Reset all filters

12 All

01 42021-05-24

02 42023-05-21

03 42027-08-01

CCSB Eltrombopag

Product Main Page

01

Gowling WLG (Canada) LLP

Eltrombopag Olamine

Coatings Trends

Not Confirmed

Gowling WLG (Canada) LLP

Canada

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-05-21

Date Granted : 2009-01-06

Eltrombopag Olamine

Brand Name : REVOLADE

Patent Number : 2486697

Filing Date : 2003-05-21

Strength per Unit : 25 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-05-21

Date Granted : 2009-01-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling WLG (Canada) LLP

Eltrombopag Olamine

Coatings Trends

Not Confirmed

Gowling WLG (Canada) LLP

Canada

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-05-24

Date Granted : 2008-04-15

Eltrombopag Olamine

Brand Name : REVOLADE

Patent Number : 2411468

Filing Date : 2001-05-24

Strength per Unit : 25 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-05-24

Date Granted : 2008-04-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling WLG (Canada) LLP

Eltrombopag Olamine

Coatings Trends

Not Confirmed

Gowling WLG (Canada) LLP

Canada

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-08-01

Date Granted : 2013-11-26

Eltrombopag Olamine

Brand Name : REVOLADE

Patent Number : 2685831

Filing Date : 2007-08-01

Strength per Unit : 25 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2027-08-01

Date Granted : 2013-11-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Gowling WLG (Canada) LLP

Eltrombopag Olamine

Coatings Trends

Not Confirmed

Gowling WLG (Canada) LLP

Canada

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-05-21

Date Granted : 2009-01-06

Eltrombopag Olamine

Brand Name : REVOLADE

Patent Number : 2486697

Filing Date : 2003-05-21

Strength per Unit : 50 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-05-21

Date Granted : 2009-01-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Gowling WLG (Canada) LLP

Eltrombopag Olamine

Coatings Trends

Not Confirmed

Gowling WLG (Canada) LLP

Canada

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-05-24

Date Granted : 2008-04-15

Eltrombopag Olamine

Brand Name : REVOLADE

Patent Number : 2411468

Filing Date : 2001-05-24

Strength per Unit : 50 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-05-24

Date Granted : 2008-04-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Gowling WLG (Canada) LLP

Eltrombopag Olamine

Coatings Trends

Not Confirmed

Gowling WLG (Canada) LLP

Canada

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-08-01

Date Granted : 2013-11-26

Eltrombopag Olamine

Brand Name : REVOLADE

Patent Number : 2685831

Filing Date : 2007-08-01

Strength per Unit : 50 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2027-08-01

Date Granted : 2013-11-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Gowling WLG (Canada) LLP

ELTROMBOPAG OLAMINE

Coatings Trends

Not Confirmed

Gowling WLG (Canada) LLP

Canada

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-08-01

Date Granted : 2013-11-06

ELTROMBOPAG OLAMINE

Brand Name : REVOLADE

Patent Number : 2685831

Filing Date : 2007-08-01

Strength per Unit : 75 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-08-01

Date Granted : 2013-11-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Gowling WLG (Canada) LLP

ELTROMBOPAG OLAMINE

Coatings Trends

Not Confirmed

Gowling WLG (Canada) LLP

Canada

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-05-24

Date Granted : 2008-04-15

ELTROMBOPAG OLAMINE

Brand Name : REVOLADE

Patent Number : 2411468

Filing Date : 2001-05-24

Strength per Unit : 75 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2021-05-24

Date Granted : 2008-04-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Gowling WLG (Canada) LLP

ELTROMBOPAG OLAMINE

Coatings Trends

Not Confirmed

Gowling WLG (Canada) LLP

Canada

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-05-21

Date Granted : 2009-01-06

ELTROMBOPAG OLAMINE

Brand Name : REVOLADE

Patent Number : 2486697

Filing Date : 2003-05-21

Strength per Unit : 75 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2023-05-21

Date Granted : 2009-01-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Gowling WLG (Canada) LLP

ELTROMBOPAG OLAMINE

Coatings Trends

Not Confirmed

Gowling WLG (Canada) LLP

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-08-01

Date Granted : 2013-11-26

ELTROMBOPAG OLAMINE

Brand Name : REVOLADE

Patent Number : 2685831

Filing Date : 2007-08-01

Strength per Unit : 12.5 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-08-01

Date Granted : 2013-11-26

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!